Latest Breaking News On - Brett novey - Page 5 : comparemela.com

Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company

Cronos Group Pays $110.4 Million for Option to Acquire 10.5% of Private MSO PharmaCann – New Cannabis Ventures

Cronos Group Inc. (CRON) Announces Strategic Investment in PharmaCann

Cronos Group (CRON) to Invest in U.S. Cannabis Company PharmaCann

List: Top Cannabis Executives, Advocates, Regulators in New York

Courtesy of Jen Drake, Crystal Peoples-Stokes, Allen Gandelman, Gia Morón; Shayanne Gal/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Meet the lawmakers, regulators, executives, and investors shaping the future of New York s cannabis industry. New York legalized cannabis on March 31 and sales are expected to start in 2022. New York legalized cannabis for adults over the age of 21 in March, setting off a gold rush for companies looking to take advantage of the potentially $7 billion market in the US s financial capital. Right now, there are only ten cannabis licenses in the state s medical market, and the companies that own each license will look to quickly transition from New York s relatively limited medical market to the recreational market.